FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Quality System Violations Found at Fresenius Facility

[ Price : $8.95]

FDAs New England District Office warns Fresenius over Quality System problems at its Waltham, MA, manufacturing facility for kidne...

Gen-Probe Seeks Assay Clearance for Trichomonas Assay

[ Price : $8.95]

Gen-Probe submits a 510(k) for the Aptima Trichomonas Vaginalis assay and its use on the company's Tigris system.

Industry, Advocates Disagree on 510(k) Changes

[ Price : $8.95]

Two industry associations voice caution over some of FDAs recommendations for changing the 510(k) process while a citizen advocacy...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Absolute Packaging, Actelion Pharma, Amigo Mobility, BCIW, Capricorn Pharma, Fre...

FDA Grant Awards for TB Research

[ Price : $8.95]

FDA awards $2.9 million to support six research projects on tuberculosis diagnosis, treatment, and prevention.

Sharfstein Says REMS Allows Drugs to Remain on Market

[ Price : $8.95]

FDA principal deputy commissioner Joshua Sharfstein says that without the ability to impose a REMS, FDA probably would have had to...

Modifications to Device Standards Published

[ Price : $8.95]

Federal Register Notice: FDA releases its modifications to the list of recognized consensus standards for use in premarket device ...

FDA Clears Orthovita Dental Bone Grafting Material

[ Price : $8.95]

Orthovita, Inc. receives FDA 510(k) clearance to market its Vitomatrix Bone Graft Substitute as bone grafting material for use in ...

FDA Faulted on Orphan Drug Development

[ Price : $8.95]

A new Institute of Medicine report on orphan drugs makes a number of recommendations for changes in CDER and CDRH activities.

Google Pushes Drug Companies to Test Ads

[ Price : $8.95]

Google wants drug marketers to test an online ad format using a drugs name, indications, and risk information.